MaltSci 麦伴科研

Appearance

Popular Reports / Immunology

This report is written by MaltSci based on the latest literature and research findings

How do dendritic cells initiate immune responses? ​

Abstract ​

Dendritic cells (DCs) are pivotal in orchestrating immune responses, acting as the primary antigen-presenting cells that link the innate and adaptive immune systems. Their role in initiating and regulating immune responses is crucial for host defense against pathogens and for maintaining immune tolerance. This review delves into the complex biology of dendritic cells, emphasizing their mechanisms of antigen uptake, processing, and presentation, alongside their interactions with various environmental signals. DCs can be classified into distinct subsets, each with specialized functions that influence T cell activation and the immune landscape. Recent research has demonstrated that DC activation is modulated by various signals, including cytokines and pathogen-associated molecular patterns (PAMPs), which dictate the nature of the immune response. Additionally, the migration of DCs from peripheral tissues to lymph nodes is a critical step in activating naive T cells, highlighting the importance of spatial dynamics in immune response initiation. The review also discusses the dual role of DCs in maintaining immune tolerance and their involvement in autoimmune diseases. Furthermore, it highlights the therapeutic implications of targeting dendritic cells in vaccine development and cancer immunotherapy. By synthesizing recent advances in dendritic cell research, this review provides a comprehensive overview of their critical role in immune responses, enhancing our understanding of basic immunology and its applications in therapeutic contexts.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Overview of Dendritic Cells
    • 2.1 Classification of Dendritic Cell Subsets
    • 2.2 Development and Maturation of Dendritic Cells
  • 3 Mechanisms of Antigen Uptake and Processing
    • 3.1 Pathways of Antigen Uptake
    • 3.2 Antigen Processing and Presentation
  • 4 Activation of T Cells by Dendritic Cells
    • 4.1 Co-stimulatory Signals
    • 4.2 Cytokine Production and T Cell Differentiation
  • 5 Dendritic Cells in Immune Tolerance and Autoimmunity
    • 5.1 Role in Immune Tolerance
    • 5.2 Dendritic Cells in Autoimmune Diseases
  • 6 Therapeutic Implications of Dendritic Cell Function
    • 6.1 Dendritic Cells in Vaccination Strategies
    • 6.2 Targeting Dendritic Cells in Cancer Immunotherapy
  • 7 Conclusion

1 Introduction ​

Dendritic cells (DCs) are critical components of the immune system, acting as the primary antigen-presenting cells that link the innate and adaptive immune responses. Their pivotal role in initiating and regulating immune responses makes them indispensable for the host's defense against pathogens, as well as for maintaining immune tolerance. Understanding the mechanisms by which dendritic cells activate T cells and other immune cells is crucial for advancing therapeutic strategies in vaccine development and immunotherapy. This review aims to elucidate the complex biology of dendritic cells, focusing on their functions in antigen uptake, processing, and presentation, as well as their interactions with various signals from the microenvironment.

The significance of dendritic cells in immunology cannot be overstated. They are uniquely positioned to recognize and respond to a wide array of antigens, distinguishing between self and foreign substances through a sophisticated network of pattern recognition receptors. This ability enables them to initiate protective adaptive immune responses when encountering pathogens, while also promoting tolerance under non-inflammatory conditions [1]. The diverse functions of dendritic cells are influenced by their developmental origins, with distinct subsets exhibiting specialized roles in the immune response [2][3]. For instance, myeloid, lymphoid, and plasmacytoid dendritic cells have been identified, each contributing uniquely to T cell activation and the overall immune landscape [3].

Current research has expanded our understanding of how dendritic cells initiate immune responses. Studies have shown that the activation of dendritic cells is influenced by various environmental signals, including cytokines and pathogen-associated molecular patterns (PAMPs) [4][5]. These signals not only promote dendritic cell maturation but also dictate the nature of the immune response that follows. For example, the interaction of dendritic cells with innate immune cells can shape the bias of adaptive responses, leading to tailored immunity against specific pathogens [3]. Furthermore, the migration of dendritic cells from peripheral tissues to lymph nodes is a crucial step in the activation of naive T cells, highlighting the importance of their spatial dynamics in immune response initiation [6].

The review will be organized as follows:

  1. Overview of Dendritic Cells: This section will classify the different subsets of dendritic cells and detail their development and maturation processes. Understanding these aspects is essential for appreciating their functional diversity.

  2. Mechanisms of Antigen Uptake and Processing: We will explore the various pathways through which dendritic cells capture antigens, as well as the intricate processes involved in antigen processing and presentation to T cells.

  3. Activation of T Cells by Dendritic Cells: This section will delve into the co-stimulatory signals required for T cell activation, the production of cytokines by dendritic cells, and how these factors influence T cell differentiation.

  4. Dendritic Cells in Immune Tolerance and Autoimmunity: We will discuss the role of dendritic cells in maintaining immune tolerance and their involvement in autoimmune diseases, shedding light on their dual role in immunity.

  5. Therapeutic Implications of Dendritic Cell Function: This part will highlight the potential of targeting dendritic cells in vaccination strategies and cancer immunotherapy, emphasizing their therapeutic relevance.

  6. Conclusion: Finally, we will summarize the key findings and implications of dendritic cell biology in the context of immune responses.

By synthesizing recent advances in dendritic cell research, this review aims to provide a comprehensive overview of their critical role in orchestrating immune responses, thereby enhancing our understanding of basic immunology and its applications in therapeutic contexts.

2 Overview of Dendritic Cells ​

2.1 Classification of Dendritic Cell Subsets ​

Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in the initiation and regulation of immune responses. They are essential for bridging the innate and adaptive immune systems, effectively shaping the nature of the immune response based on the context of antigen encounter.

DCs initiate immune responses by internalizing, processing, and presenting antigens to T cells. They are equipped with a variety of microbial sensors that allow them to distinguish between self and foreign antigens. Upon capturing an antigen, DCs process it into proteolytic peptides, which are then loaded onto major histocompatibility complex (MHC) class I and II molecules. Following this, DCs migrate to secondary lymphoid organs, where they present these antigens to T lymphocytes, thereby triggering antigen-specific immune responses or promoting immunological tolerance, depending on the signals received during antigen capture [1][7].

The classification of dendritic cell subsets is essential for understanding their specialized functions in immune responses. DCs can be broadly categorized into several subsets, including myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs). Myeloid DCs are further divided into classical types 1 and 2, which are primarily involved in antigen processing and presentation. In contrast, pDCs are known for their strong response to viral infections through the secretion of type 1 interferons [8].

The unique capabilities of different DC subsets influence the type of immune response elicited. For instance, mDCs are adept at stimulating naive T cells, thereby playing a pivotal role in generating adaptive immunity. They also interact with cells of the innate immune system, shaping the responses of both arms of immunity [3]. The plasticity of DC responses allows them to tailor immune responses based on the nature of the pathogen and the environmental context [9].

The regulation of DC functions is a complex interplay of various signals. The activation of DCs by pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) is crucial for their maturation and ability to present antigens effectively. This maturation process is influenced by the local microenvironment, which can dictate whether a DC promotes immunity or tolerance [5].

In summary, dendritic cells are central to the initiation of immune responses through their unique ability to process and present antigens, their classification into distinct subsets, and their capacity to respond to a wide range of signals from both pathogens and the host environment. Understanding these mechanisms provides valuable insights into designing effective immunotherapies and vaccination strategies [10][11].

2.2 Development and Maturation of Dendritic Cells ​

Dendritic cells (DCs) are essential antigen-presenting cells that play a pivotal role in initiating and regulating immune responses. Their unique ability to capture, process, and present antigens to T cells distinguishes them from other immune cells. The initiation of immune responses by dendritic cells involves several key processes, including their development, maturation, and interaction with T cells.

Dendritic cells originate from bone marrow stem cells and undergo a series of developmental stages before becoming fully functional. Initially, blood monocytes, specifically CD14+ cells, can differentiate into dendritic cells when cultured under specific conditions with cytokines such as granulocyte-monocyte colony-stimulating factor (GM-CSF), interleukin-4 (IL-4), and tumor necrosis factor alpha (TNF-α). This process leads to the formation of CD1a+ CD83+ dendritic cells, which exhibit all the characteristics of mature dendritic cells and are capable of robustly stimulating T cell responses in allogeneic mixed leukocyte reactions (Zhou & Tedder, 1996) [12].

The maturation of dendritic cells is a critical step that occurs in response to various stimuli, including pathogens and inflammatory signals. Immature dendritic cells (iDCs) are adept at phagocytizing pathogens and processing them into peptide fragments, which are then presented on major histocompatibility complex (MHC) class II molecules to naïve T cells. As iDCs mature, they cease antigen uptake and migrate to secondary lymphoid organs, such as lymph nodes and the spleen. During this migration, DCs upregulate the expression of costimulatory molecules, including CD80, CD86, and CD83, which are crucial for T cell activation (Mbongue et al., 2017) [13].

The interaction between mature dendritic cells and T cells is finely regulated. When DCs present antigens to naïve T cells, the engagement of T cell receptors (TCRs) with MHC-peptide complexes, along with the binding of costimulatory receptors (e.g., CD28 on T cells binding to CD80/CD86 on DCs), leads to T cell activation. This interaction prompts the secretion of cytokines such as IL-12 or IL-10, which further influence T cell differentiation into pro-inflammatory or anti-inflammatory subsets (Johnson & Ohashi, 2013) [14].

Furthermore, the maturation of dendritic cells is accompanied by a series of molecular changes that enhance their immunogenicity. For instance, the regulated ubiquitination of MHC class II molecules is critical for their surface expression during maturation, allowing dendritic cells to present antigens effectively (Shin et al., 2006) [15]. This maturation process is essential not only for the activation of T cells but also for the establishment of immunological memory and tolerance.

In summary, dendritic cells initiate immune responses through a well-coordinated process involving their development from precursor cells, maturation in response to various stimuli, and the subsequent interaction with T cells. These processes enable dendritic cells to serve as crucial regulators of both innate and adaptive immunity, making them central to the body's defense against pathogens and the maintenance of immune homeostasis.

3 Mechanisms of Antigen Uptake and Processing ​

3.1 Pathways of Antigen Uptake ​

Dendritic cells (DCs) play a crucial role in the initiation of immune responses through their unique mechanisms of antigen uptake and processing. They are the most efficient antigen-presenting cells and are essential for the activation of T lymphocytes, which is a key step in both adaptive immune responses and the induction of immunological tolerance.

Dendritic cells are capable of capturing antigens in peripheral tissues where they reside. This process involves the internalization of antigens, which can include pathogens and other foreign materials. Upon uptake, DCs process these antigens into proteolytic peptides. These peptides are then loaded onto major histocompatibility complex (MHC) class I and II molecules. The MHC-peptide complexes are subsequently transported to the cell surface, where they can be presented to T cells (Guermonprez et al. 2002) [7].

The uptake of antigens by dendritic cells is finely regulated and differs from other antigen-presenting cells. This regulation encompasses several stages: antigen uptake, intracellular transport, degradation, and the trafficking of MHC molecules. Dendritic cells utilize specialized membrane transport pathways that facilitate the efficient processing and presentation of antigens (Théry and Amigorena 2001) [16].

Once the dendritic cells have processed the antigens, they migrate from the sites of antigen acquisition to secondary lymphoid organs. This migration is crucial as it allows the DCs to become competent in presenting antigens to T lymphocytes. In the lymphoid organs, dendritic cells interact physically with T cells, providing the necessary signals for T cell activation. This interaction is pivotal for initiating antigen-specific immune responses (Delamarre and Mellman 2011) [1].

Dendritic cells also possess the ability to distinguish between self and foreign antigens using a wide array of microbial sensors. This capability is essential for determining whether to induce an immune response or tolerance, depending on the context in which the antigen is captured (Delamarre and Mellman 2011) [1].

In summary, dendritic cells initiate immune responses through a series of well-regulated processes involving antigen uptake, processing, migration, and interaction with T cells. These processes underscore the specialized functions of dendritic cells in both the activation of immune responses and the maintenance of tolerance.

3.2 Antigen Processing and Presentation ​

Dendritic cells (DCs) are pivotal in the initiation and regulation of immune responses, functioning primarily as antigen-presenting cells. They play a crucial role in capturing, processing, and presenting antigens to T lymphocytes, thereby initiating both adaptive immune responses and immunological tolerance.

Upon encountering antigens in peripheral tissues, dendritic cells engage in a multi-step process to effectively present these antigens. Initially, DCs take up antigens through various mechanisms, including phagocytosis, endocytosis, and pinocytosis. This uptake allows them to internalize pathogens and other foreign proteins, which are then processed into proteolytic peptides. These peptides are subsequently loaded onto major histocompatibility complex (MHC) class I and II molecules, which are essential for T cell recognition and activation [7].

Once the antigens are processed, dendritic cells migrate from the sites of antigen acquisition to secondary lymphoid organs, such as lymph nodes. During this migration, they undergo maturation, which enhances their ability to present antigens and provide co-stimulatory signals necessary for T cell activation. This maturation process involves the upregulation of MHC molecules and the expression of various co-stimulatory molecules that are critical for the effective interaction with T cells [[pmid:11154916], [pmid:19025715]].

The interaction between dendritic cells and T cells is finely regulated. Upon reaching the lymphoid organs, mature dendritic cells present the processed antigen-MHC complexes to naïve T cells. This interaction is essential for the activation of T cells, which subsequently proliferate and differentiate into effector cells capable of mounting an immune response [[pmid:11861614], [pmid:36936763]]. Dendritic cells not only activate T cells but also play a role in the induction of tolerance by presenting self-antigens, thereby preventing autoimmune responses [17].

Moreover, the antigen presentation process is not merely a passive event. Dendritic cells are equipped with specialized membrane transport pathways that regulate the intracellular trafficking of MHC-peptide complexes to the cell surface. This ensures that the antigen presentation is timely and efficient, allowing for a rapid immune response to infections [[pmid:11154916], [pmid:11861614]].

In summary, dendritic cells initiate immune responses through a well-coordinated process of antigen uptake, processing, and presentation. They are uniquely positioned to bridge innate and adaptive immunity, making them essential for the effective functioning of the immune system. Their ability to not only activate T cells but also induce tolerance highlights their critical role in maintaining immune homeostasis [[pmid:9521319], [pmid:19025715]].

4 Activation of T Cells by Dendritic Cells ​

4.1 Co-stimulatory Signals ​

Dendritic cells (DCs) are critical antigen-presenting cells that play a pivotal role in the initiation and regulation of immune responses. They achieve this by providing essential signals that activate T cells, which are key mediators of adaptive immunity. The activation of T cells by dendritic cells occurs through a two-signal mechanism, which is fundamental for effective immune responses.

The first signal involves the specific recognition of antigens. This is mediated by the interaction between antigen-presenting major histocompatibility complexes (MHC) on dendritic cells and T cell receptors (TCR) on naive T cells. This interaction ensures that T cells are activated in an antigen-specific manner, leading to their entry into the cell cycle and subsequent proliferation[18].

The second signal, known as the co-stimulatory signal, is equally important for the full activation of T cells. Dendritic cells express various co-stimulatory molecules, such as members of the B7 family (CD80/CD86), which interact with receptors on T cells, such as CD28. This interaction is crucial for T cell expansion and cytokine production, thereby enhancing the immune response[19].

In addition to these primary signals, dendritic cells also provide cytokines that help polarize T cells into different effector populations. This third signal, which is referred to as signal III, influences the differentiation of T cells into various types of helper T cells (e.g., Th1, Th2) or cytotoxic T cells (CD8+), thereby shaping the overall immune response[20]. The combination of these signals ensures that T cells not only become activated but also acquire the necessary functional properties to effectively combat pathogens.

Furthermore, dendritic cells exhibit considerable heterogeneity in their subsets, which can respond differently depending on the type of pathogen encountered. This transcriptional plasticity allows dendritic cells to tailor their responses according to the specific infectious agent, thus optimizing the immune response[21]. The interaction of dendritic cells with other components of the immune system, including innate immune cells, further influences the adaptive immune response and contributes to the overall balance between immunity and tolerance[3].

In summary, dendritic cells initiate immune responses by providing a combination of antigen-specific signals, co-stimulatory signals, and cytokines that collectively activate and polarize T cells. This intricate interplay is essential for the generation of effective adaptive immunity against a wide array of pathogens.

4.2 Cytokine Production and T Cell Differentiation ​

Dendritic cells (DCs) play a pivotal role in initiating immune responses, particularly in the activation of T cells and the production of cytokines that drive T cell differentiation. As the most potent antigen-presenting cells in the immune system, dendritic cells are essential for the priming of T cell responses, facilitating the transition from innate to adaptive immunity.

The activation of T cells by dendritic cells begins when DCs capture and process antigens. Immature dendritic cells sample antigens from their environment and, upon activation—often triggered by pathogen-associated molecular patterns (PAMPs) and cytokines—they mature and migrate to lymphoid tissues. In these tissues, they present processed antigenic peptides on major histocompatibility complex (MHC) molecules to naive T cells. This interaction is crucial, as it not only activates the T cells but also determines their subsequent differentiation into various effector populations, such as T helper (Th) cells or cytotoxic T lymphocytes (CTLs) [20].

Dendritic cells provide both T-cell-receptor ligands and co-stimulatory signals necessary for naive T cell activation. The co-stimulatory molecules, such as CD80/CD86, engage with CD28 on T cells, enhancing their activation. Additionally, dendritic cells produce a variety of cytokines that influence T cell differentiation. For instance, the presence of interleukin-12 (IL-12) can drive the differentiation of naive CD4+ T cells into Th1 cells, which are important for cell-mediated immunity, while IL-4 promotes the differentiation into Th2 cells, which are involved in humoral immunity [10].

The mechanisms underlying the differentiation of T cells by dendritic cells are complex and involve the interplay of various signals. Dendritic cells exhibit heterogeneity in their phenotype and functional capabilities, which is influenced by their developmental lineage, maturation state, and the tissue environment. This heterogeneity allows different subsets of dendritic cells to tailor their responses according to the type of pathogen encountered, thus shaping the nature of the immune response [3][20].

Furthermore, dendritic cells can influence the balance between Th1 and Th2 responses through the secretion of specific cytokines. For example, the production of cytokines like IL-10 and transforming growth factor-beta (TGF-β) can promote regulatory T cell (Treg) responses, which are essential for maintaining immune tolerance and preventing excessive inflammatory responses [5]. This ability to modulate T cell responses underscores the critical role of dendritic cells in not only initiating immune responses but also in regulating their outcomes.

In summary, dendritic cells initiate immune responses by capturing and processing antigens, activating naive T cells through specific receptor interactions and co-stimulatory signals, and producing cytokines that guide T cell differentiation. Their unique capabilities as antigen-presenting cells enable them to bridge the innate and adaptive immune systems, ensuring a tailored immune response appropriate to the encountered pathogen.

5 Dendritic Cells in Immune Tolerance and Autoimmunity ​

5.1 Role in Immune Tolerance ​

Dendritic cells (DCs) play a crucial role in the initiation of immune responses, acting as professional antigen-presenting cells that bridge innate and adaptive immunity. Their ability to process and present antigens is fundamental to the activation of T lymphocytes, which are essential for orchestrating immune responses. DCs take up antigens in peripheral tissues, process them into proteolytic peptides, and load these peptides onto major histocompatibility complex (MHC) class I and II molecules. After processing, DCs migrate to secondary lymphoid organs, where they present the processed antigens to T cells, thus initiating antigen-specific immune responses or inducing immunological tolerance [7].

The unique properties of DCs allow them to shape both the innate and adaptive immune responses. In a steady state, immature DCs continuously capture self-antigens and innocuous environmental proteins while circulating through tissues. This process helps establish peripheral tolerance by either deleting self-reactive T cells or expanding regulatory T cells (Tregs) [22]. The balance between immune activation and tolerance is critical, as dysregulation can lead to autoimmunity. In this context, DCs are implicated in the pathogenesis of various autoimmune diseases, where their role in maintaining tolerance is disrupted [23].

DCs are also involved in the negative selection of autoreactive T cells in the thymus, contributing to central tolerance. In the periphery, they can induce tolerance through various mechanisms, including T-cell deletion, generation of Tregs, and induction of T-cell anergy, which is characterized by a state of unresponsiveness to self-antigens [24]. The modulation of immune responses by DCs can occur both constitutively and in inflammatory conditions, helping to prevent autoimmunity [25].

Moreover, the metabolic state of DCs influences their functional outcome. While mature DCs typically promote immune activation, tolerogenic DCs favor metabolic pathways that enhance their ability to induce tolerance [26]. This metabolic reprogramming is essential for their role in maintaining homeostasis and preventing autoimmune diseases [27].

In summary, dendritic cells are pivotal in initiating immune responses through their specialized functions in antigen presentation and their ability to modulate T-cell responses. Their role in establishing and maintaining immune tolerance is equally critical, as it prevents the development of autoimmunity by ensuring that self-reactive T cells are effectively managed. The intricate balance of DC function in both immunity and tolerance underscores their importance in the immune system and their potential as therapeutic targets in autoimmune disorders.

5.2 Dendritic Cells in Autoimmune Diseases ​

Dendritic cells (DCs) are integral to the initiation and shaping of immune responses, acting as professional antigen-presenting cells that link the innate and adaptive immune systems. Their unique ability to capture, process, and present antigens to T cells positions them at the forefront of immune activation.

Upon encountering pathogens or stress signals, dendritic cells undergo a maturation process that enhances their ability to stimulate T cells. This process is triggered by innate pattern recognition pathways that recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [5]. During this activation, DCs not only present antigens but also express co-stimulatory molecules that are crucial for T-cell activation [23].

The maturation of dendritic cells is influenced by their microenvironment. For instance, tissue-derived environmental factors play a role in shaping the functional activity of activated DCs, thereby tailoring the immune response to match the nature of the infection [5]. In healthy individuals, resting and tolerogenic DCs help maintain peripheral immune tolerance by promoting the expansion of regulatory T cells (Tregs) [28]. However, in the context of autoimmune diseases, DCs can become activated inappropriately, leading to the expansion of self-reactive effector T cells and the promotion of chronic inflammation [28].

Dendritic cells have been shown to play a dual role in autoimmunity. They can initiate autoimmune responses by presenting self-antigens in a manner that leads to the activation of autoreactive T cells [29]. Conversely, they can also inhibit T cell-mediated autoimmune diseases through mechanisms that induce peripheral T cell tolerance [30]. The balance between these opposing functions is crucial for the maintenance of immune homeostasis and the prevention of autoimmune pathology.

In specific autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis, dendritic cells have been implicated in the disease pathogenesis. They are involved in the generation of pathogenic immune responses that contribute to the progression of these disorders [31][32]. In rheumatoid arthritis, for example, while the role of DCs in initiating autoimmunity remains uncertain, they are believed to play a significant role in disease maintenance and progression [32].

Recent research has focused on the therapeutic potential of targeting dendritic cells in autoimmune diseases. By manipulating DCs to enhance their tolerogenic properties, it may be possible to suppress inappropriate immune responses and restore immune regulation [28][33]. This approach could involve generating tolerogenic DCs ex vivo, which can then be used to induce immune tolerance in vivo [32].

In summary, dendritic cells are pivotal in initiating immune responses through their ability to present antigens and modulate T cell activity. Their dual role in promoting and inhibiting autoimmunity underscores the complexity of their functions in both health and disease, highlighting their potential as therapeutic targets in autoimmune disorders.

6 Therapeutic Implications of Dendritic Cell Function ​

6.1 Dendritic Cells in Vaccination Strategies ​

Dendritic cells (DCs) are specialized antigen-presenting cells that play a crucial role in the initiation and regulation of immune responses. They are characterized by their unique ability to capture, process, and present antigens to naive T lymphocytes, thereby facilitating the activation of T cells and the subsequent adaptive immune response. This capability is fundamental to the functioning of the immune system, as DCs serve as a bridge between the innate and adaptive immune systems.

The process of immune response initiation by dendritic cells begins with their localization at strategic sites in the body, particularly at entry points for pathogens. DCs are adept at taking up antigens through various mechanisms, including phagocytosis and endocytosis. Once they capture antigens, DCs migrate to lymphatic tissues, where they present the processed antigen in conjunction with major histocompatibility complex (MHC) molecules to naive T cells. This interaction is critical, as it is the only means by which naive T cells can be activated. The stimulation of T cells requires not only the recognition of the antigen-MHC complex but also the provision of necessary costimulatory signals, which DCs are uniquely equipped to deliver due to their expression of costimulatory and adhesion molecules [34].

Dendritic cells exhibit distinct phenotypic and functional characteristics that are closely linked to their maturation stage. Immature DCs are highly effective at capturing antigens but are not fully capable of stimulating T cells. Upon maturation, triggered by various stimuli, including pathogen-associated molecular patterns, DCs enhance their expression of MHC and costimulatory molecules, thus becoming potent activators of T cell responses [35].

In terms of therapeutic implications, the unique properties of DCs have led to their investigation as targets for vaccination strategies, particularly in the context of cancer immunotherapy. Dendritic cell-based vaccines aim to harness their antigen-presenting capabilities to elicit robust anti-tumor immune responses. This involves loading DCs with tumor-specific antigens and delivering them to patients, where they can stimulate T cells to recognize and attack cancer cells [36]. The efficacy of these vaccines can be influenced by various factors, including the choice of DC subset, the route of administration, and the incorporation of adjuvants to enhance the immune response [37].

Recent advancements have demonstrated that targeting vaccines to DCs can fine-tune the humoral immune response, allowing for better regulation of T cell polarization and enhancing antibody production [38]. Additionally, studies have shown that the incorporation of knowledge regarding DC biology into vaccine design is essential for developing effective immunotherapies for various diseases, including cancer [39].

In summary, dendritic cells initiate immune responses by capturing and presenting antigens to naive T cells, thereby activating them and facilitating the development of adaptive immunity. Their role in vaccination strategies, particularly in cancer immunotherapy, highlights their potential as powerful tools for inducing specific and effective immune responses.

6.2 Targeting Dendritic Cells in Cancer Immunotherapy ​

Dendritic cells (DCs) are pivotal in initiating immune responses, particularly in the context of cancer immunotherapy. They are characterized as a heterogeneous population of antigen-presenting cells that play a crucial role at the intersection of innate and adaptive immunity. DCs possess the unique ability to capture, process, and present tumor-associated antigens (TAAs) to naïve CD4(+) and CD8(+) T lymphocytes, thereby initiating tumor-specific immune responses (Larmonier et al. 2010) [40].

Upon encountering antigens, DCs undergo a maturation process that enhances their capacity to activate T cells. This maturation is influenced by various signals from the tumor microenvironment, including cytokines and chemokines, which can either promote or inhibit DC function (Alfei et al. 2021) [41]. The capacity of DCs to produce cytokines further regulates the type, strength, and duration of T cell immune responses, thus tailoring the immune response to effectively target tumor cells (Larmonier et al. 2010) [40].

In addition to their role in antigen presentation, recent studies have highlighted a non-conventional cytotoxic function of DCs, whereby they can directly kill cancer cells. This dual role may enhance the immediate availability of specific tumor antigens for T cell activation, thus fostering a more robust anti-tumor immune response (Larmonier et al. 2010) [40]. The interplay between DCs and T cells is further complicated by the tumor microenvironment, which can disrupt their communication and compromise the efficacy of immune responses (Alfei et al. 2021) [41].

The therapeutic implications of dendritic cell function are significant. By harnessing the capacity of DCs to prime T cells and trigger effective anti-cancer responses, various strategies have been developed for DC-based immunotherapy. These include loading DCs with tumor antigens ex vivo and reinfusing them into patients, as well as utilizing genetic modifications to enhance their immunogenicity (Mann et al. 2009) [42]. Additionally, combining DC therapy with conventional treatments such as chemotherapy and radiotherapy has shown promise in augmenting anti-tumor responses, as these modalities can enhance DC activation and function (Apetoh et al. 2011) [43].

Targeting dendritic cells in cancer immunotherapy involves not only the use of DCs as therapeutic agents but also the modulation of their function within the tumor microenvironment. Understanding how to restore or enhance DC function, particularly in the presence of immunosuppressive signals, is critical for improving the efficacy of cancer vaccines and other immunotherapeutic strategies (Gardner et al. 2020) [44]. Current research continues to explore innovative methods to optimize DC-based therapies, aiming to create more effective and personalized cancer treatment approaches (Kurilin et al. 2024) [45].

In summary, dendritic cells are essential for initiating and regulating immune responses against tumors. Their ability to present antigens and directly kill cancer cells presents unique therapeutic opportunities in cancer immunotherapy, emphasizing the need for ongoing research to fully exploit their potential in clinical applications.

7 Conclusion ​

Dendritic cells (DCs) are indispensable for initiating and regulating immune responses, serving as the primary antigen-presenting cells that connect the innate and adaptive immune systems. This review has highlighted several key findings regarding the diverse roles of dendritic cells in immune responses, including their classification into distinct subsets, the mechanisms of antigen uptake and processing, and their crucial interactions with T cells. The plasticity of dendritic cells allows them to tailor immune responses based on the nature of the encountered pathogens and the surrounding microenvironment. Current research underscores the importance of understanding how DCs can promote either immunity or tolerance, particularly in the context of autoimmune diseases and therapeutic applications such as vaccination and cancer immunotherapy. Future research should focus on elucidating the specific molecular pathways and signals that govern dendritic cell function, as well as exploring innovative strategies to harness their capabilities for therapeutic purposes. By optimizing dendritic cell-based interventions, we can enhance vaccine efficacy and develop novel immunotherapeutic approaches for various diseases, including cancer and autoimmune disorders.

References ​

  • [1] Lélia Delamarre;Ira Mellman. Harnessing dendritic cells for immunotherapy.. Seminars in immunology(IF=7.8). 2011. PMID:21377379. DOI: 10.1016/j.smim.2011.02.001.
  • [2] Jean-Claude Gluckman;Bruno Canque;Michelle Rosenzwajg. Dendritic cells: a complex simplicity.. Transplantation(IF=5.0). 2002. PMID:11810052. DOI: 10.1097/00007890-200201151-00004.
  • [3] C J Howard;B Charleston;S A Stephens;P Sopp;J C Hope. The role of dendritic cells in shaping the immune response.. Animal health research reviews(IF=5.6). 2004. PMID:15984324. DOI: 10.1079/ahr200468.
  • [4] Heung Kyu Lee;Akiko Iwasaki. Innate control of adaptive immunity: dendritic cells and beyond.. Seminars in immunology(IF=7.8). 2007. PMID:17276695. DOI: 10.1016/j.smim.2006.12.001.
  • [5] Sandra S Diebold. Determination of T-cell fate by dendritic cells.. Immunology and cell biology(IF=3.0). 2008. PMID:18382438. DOI: 10.1038/icb.2008.26.
  • [6] M Rescigno;F Granucci;P Ricciardi-Castagnoli. Dendritic cells at the end of the millennium.. Immunology and cell biology(IF=3.0). 1999. PMID:10540206. DOI: 10.1046/j.1440-1711.1999.00854.x.
  • [7] Pierre Guermonprez;Jenny Valladeau;Laurence Zitvogel;Clotilde Théry;Sebastian Amigorena. Antigen presentation and T cell stimulation by dendritic cells.. Annual review of immunology(IF=33.3). 2002. PMID:11861614. DOI: 10.1146/annurev.immunol.20.100301.064828.
  • [8] Radika Soysa;Xia Wu;I Nicholas Crispe. Dendritic cells in hepatitis and liver transplantation.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society(IF=3.9). 2017. PMID:28752938. DOI: 10.1002/lt.24833.
  • [9] Q Huang;D Liu;P Majewski;L C Schulte;J M Korn;R A Young;E S Lander;N Hacohen. The plasticity of dendritic cell responses to pathogens and their components.. Science (New York, N.Y.)(IF=45.8). 2001. PMID:11679675. DOI: 10.1126/science.294.5543.870.
  • [10] John Sinclair. Manipulation of dendritic cell functions by human cytomegalovirus.. Expert reviews in molecular medicine(IF=5.5). 2008. PMID:19025715. DOI: 10.1017/S1462399408000872.
  • [11] Francis R Carbone;William R Heath. The role of dendritic cell subsets in immunity to viruses.. Current opinion in immunology(IF=5.8). 2003. PMID:12900273. DOI: 10.1016/s0952-7915(03)00074-8.
  • [12] L J Zhou;T F Tedder. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 1996. PMID:8637918. DOI: 10.1073/pnas.93.6.2588.
  • [13] Jacques C Mbongue;Hector A Nieves;Timothy W Torrez;William H R Langridge. The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus.. Frontiers in immunology(IF=5.9). 2017. PMID:28396662. DOI: 10.3389/fimmu.2017.00327.
  • [14] Dylan J Johnson;Pamela S Ohashi. Molecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillance.. Annals of the New York Academy of Sciences(IF=4.8). 2013. PMID:23651192. DOI: 10.1111/nyas.12114.
  • [15] Jeoung-Sook Shin;Melanie Ebersold;Marc Pypaert;Lelia Delamarre;Adam Hartley;Ira Mellman. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.. Nature(IF=48.5). 2006. PMID:17051151. DOI: 10.1038/nature05261.
  • [16] C Théry;S Amigorena. The cell biology of antigen presentation in dendritic cells.. Current opinion in immunology(IF=5.8). 2001. PMID:11154916. DOI: 10.1016/s0952-7915(00)00180-1.
  • [17] J Banchereau;R M Steinman. Dendritic cells and the control of immunity.. Nature(IF=48.5). 1998. PMID:9521319. DOI: 10.1038/32588.
  • [18] J W Hodge;A N Rad;D W Grosenbach;H Sabzevari;A G Yafal;L Gritz;J Schlom. Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.. Journal of the National Cancer Institute(IF=7.2). 2000. PMID:10922408. DOI: 10.1093/jnci/92.15.1228.
  • [19] Ghaith Bakdash;Simone P Sittig;Tjeerd van Dijk;Carl G Figdor;I Jolanda M de Vries. The nature of activatory and tolerogenic dendritic cell-derived signal II.. Frontiers in immunology(IF=5.9). 2013. PMID:23450201. DOI: 10.3389/fimmu.2013.00053.
  • [20] Kerry L Hilligan;Franca Ronchese. Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses.. Cellular & molecular immunology(IF=19.8). 2020. PMID:32433540. DOI: 10.1038/s41423-020-0465-0.
  • [21] Mubeen M Mosaheb;Michael C Brown;Elena Y Dobrikova;Mikhail I Dobrikov;Matthias Gromeier. Harnessing virus tropism for dendritic cells for vaccine design.. Current opinion in virology(IF=5.1). 2020. PMID:32771959. DOI: 10.1016/j.coviro.2020.07.012.
  • [22] Ralph Marvin Steinman;Michel C Nussenzweig. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 2002. PMID:11773639. DOI: 10.1073/pnas.231606698.
  • [23] Dipyaman Ganguly;Stefan Haak;Vanja Sisirak;Boris Reizis. The role of dendritic cells in autoimmunity.. Nature reviews. Immunology(IF=60.9). 2013. PMID:23827956. DOI: 10.1038/nri3477.
  • [24] Hitoshi Hasegawa;Takuya Matsumoto. Mechanisms of Tolerance Induction by Dendritic Cells In Vivo.. Frontiers in immunology(IF=5.9). 2018. PMID:29535726. DOI: 10.3389/fimmu.2018.00350.
  • [25] Angus G Thompson;Ranjeny Thomas. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease.. Immunology and cell biology(IF=3.0). 2002. PMID:12406384. DOI: 10.1046/j.1440-1711.2002.01114.x.
  • [26] Wen Jing Sim;Patricia Jennifer Ahl;John Edward Connolly. Metabolism Is Central to Tolerogenic Dendritic Cell Function.. Mediators of inflammation(IF=4.2). 2016. PMID:26980944. DOI: 10.1155/2016/2636701.
  • [27] Maisa C Takenaka;Francisco J Quintana. Tolerogenic dendritic cells.. Seminars in immunopathology(IF=9.2). 2017. PMID:27646959. DOI: 10.1007/s00281-016-0587-8.
  • [28] Benjamin Cai;Ranjeny Thomas. Dendritic cells and antigen-specific immunotherapy in autoimmune rheumatic diseases.. Best practice & research. Clinical rheumatology(IF=4.8). 2024. PMID:38485600. DOI: 10.1016/j.berh.2024.101940.
  • [29] Consuelo M López de Padilla;Ann M Reed. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.. Current opinion in rheumatology(IF=4.3). 2008. PMID:18946326. DOI: 10.1097/BOR.0b013e3283157538.
  • [30] Shannon J Turley. Dendritic cells: inciting and inhibiting autoimmunity.. Current opinion in immunology(IF=5.8). 2002. PMID:12413527. DOI: 10.1016/s0952-7915(02)00399-0.
  • [31] F J Quintana;A Yeste;I D Mascanfroni. Role and therapeutic value of dendritic cells in central nervous system autoimmunity.. Cell death and differentiation(IF=15.4). 2015. PMID:25168240. DOI: 10.1038/cdd.2014.125.
  • [32] Shaukat Khan;Jeffrey D Greenberg;Nina Bhardwaj. Dendritic cells as targets for therapy in rheumatoid arthritis.. Nature reviews. Rheumatology(IF=32.7). 2009. PMID:19798032. DOI: 10.1038/nrrheum.2009.185.
  • [33] Xing Li;Yanping Han;Erwei Sun. Sniping the scout: Targeting the key molecules in dendritic cell functions for treatment of autoimmune diseases.. Pharmacological research(IF=10.5). 2016. PMID:26931618. DOI: 10.1016/j.phrs.2016.02.023.
  • [34] D Avigan. Dendritic cells: development, function and potential use for cancer immunotherapy.. Blood reviews(IF=5.7). 1999. PMID:10225609. DOI: 10.1016/s0268-960x(99)90023-1.
  • [35] Camilla Foged;Anne Sundblad;Lars Hovgaard. Targeting vaccines to dendritic cells.. Pharmaceutical research(IF=4.3). 2002. PMID:11934227. DOI: 10.1023/a:1014474414097.
  • [36] Matthias Schott. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.. Endocrine-related cancer(IF=4.6). 2006. PMID:16954430. DOI: 10.1677/erc.1.01133.
  • [37] Demo Yemane Tesfaye;Arnar Gudjonsson;Bjarne Bogen;Even Fossum. Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses.. Frontiers in immunology(IF=5.9). 2019. PMID:31333661. DOI: 10.3389/fimmu.2019.01529.
  • [38] Sara Nava;Daniela Lisini;Simona Frigerio;Anna Bersano. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.. International journal of molecular sciences(IF=4.9). 2021. PMID:34830221. DOI: 10.3390/ijms222212339.
  • [39] Shin-ichiro Fujii;Takuya Takayama;Miki Asakura;Kaori Aki;Koji Fujimoto;Kanako Shimizu. Dendritic cell-based cancer immunotherapies.. Archivum immunologiae et therapiae experimentalis(IF=3.9). 2009. PMID:19479202. DOI: 10.1007/s00005-009-0025-x.
  • [40] Nicolas Larmonier;Jennifer Fraszczak;Daniela Lakomy;Bernard Bonnotte;Emmanuel Katsanis. Killer dendritic cells and their potential for cancer immunotherapy.. Cancer immunology, immunotherapy : CII(IF=5.1). 2010. PMID:19618185. DOI: 10.1007/s00262-009-0736-1.
  • [41] Francesca Alfei;Ping-Chih Ho;Wan-Lin Lo. DCision-making in tumors governs T cell anti-tumor immunity.. Oncogene(IF=7.3). 2021. PMID:34290401. DOI: 10.1038/s41388-021-01946-8.
  • [42] Dean L Mann;Christina M Celluzzi;Kim G Hankey;Kristina M Harris;Ryuko Watanabe;Kenichiro Hasumi. Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers.. Annals of the New York Academy of Sciences(IF=4.8). 2009. PMID:19769735. DOI: 10.1111/j.1749-6632.2009.04934.x.
  • [43] Lionel Apetoh;Clara Locher;François Ghiringhelli;Guido Kroemer;Laurence Zitvogel. Harnessing dendritic cells in cancer.. Seminars in immunology(IF=7.8). 2011. PMID:21295491. DOI: 10.1016/j.smim.2011.01.003.
  • [44] Alycia Gardner;Álvaro de Mingo Pulido;Brian Ruffell. Dendritic Cells and Their Role in Immunotherapy.. Frontiers in immunology(IF=5.9). 2020. PMID:32508825. DOI: 10.3389/fimmu.2020.00924.
  • [45] Vasily Kurilin;Alina Alshevskaya;Sergey Sennikov. Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases.. Biomedicines(IF=3.9). 2024. PMID:38540312. DOI: 10.3390/biomedicines12030699.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Dendritic Cells · Immune Response · Antigen Presentation · Immune Tolerance · Cancer Immunotherapy

© 2025 MaltSci